| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f0081ada8e4c831b2f158ced70f47c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74e5a937ae6dd7f4a4921b45e169b1a0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 |
| filingDate |
1993-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44fb2a48af2c3a234d5b8577a147f952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001e2db0e9d2038c74a1cf129beeffde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f18632506b9941cd5185b45b898d9b |
| publicationDate |
1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2120803-C1 |
| titleOfInvention |
Method of prophylaxis and treatment of patients with peripheral neuropathy, composition containing insulin-like growth factor-1 |
| abstract |
FIELD: medicine, neurology. SUBSTANCE: method involves administration of insulin-like growth factor-1 to patients with neuropathy caused by not abnormal insulin level at dose that decreases neuropathy symptoms. Composition for decrease of peripheral neuropathy caused by neurotoxic agent has practically pure insulin-like growth factor-1 and neurotoxic chemotherapeutic agent at mass ratio from 1:400 to 75:1. EFFECT: enhanced effectiveness of treatment. 20 cl, 6 tbl, 5 dwg |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2492137-C2 |
| priorityDate |
1992-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |